SGLT2 Inhibitor Use Associated With Lower Proteinuria Rates During Bevacizumab Therapy
A retrospective cohort study found that concomitant SGLT2 inhibitor use was associated with a significantly lower incidence of grade 2 ...
A retrospective cohort study found that concomitant SGLT2 inhibitor use was associated with a significantly lower incidence of grade 2 ...
Preclinical glioblastoma models reveal that tumors evade anti-VEGF therapy by activating a transient neuronal-like remodeling program driven by the CTNNB1–NRG3–ERBB4 ...
A retrospective study reveals frequent local progression and identifies tumor volume as a significant risk factor following CyberKnife radiosurgery for ...
Triple-negative breast cancer, defined by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression, ...
A clinical case report demonstrates that combining trifluridine/tipiracil plus bevacizumab with stereotactic radiofrequency ablation produced thirty-four months of overall survival ...
A narrative review evaluates trial evidence indicating that KELIM chemosensitivity scores, rather than BRCA or homologous recombination deficiency status, predict ...
A case report documents the regression of presumed brain metastases and 15-month survival in a 51-year-old cervical cancer patient treated ...
A comprehensive genomic review reveals how cancer stem cells, viral integration, and clonal signaling pathways drive hepatocellular carcinoma, highlighting emerging ...
A narrative review outlines a cardio-neuro-oncology framework to address cardiovascular toxicities and overlapping clinical complications across contemporary central nervous system ...
A single-center retrospective study linked multi-target TKIs plus immunotherapy to longer survival than bevacizumab regimens in advanced hepatocellular carcinoma.
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine